Mustang Bio Inc (MBIO)
0.28
-0.02
(-7.04%)
USD |
NASDAQ |
May 07, 14:12
Mustang Bio Price to Book Value: 23.65 for May 7, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 25.44 |
| May 03, 2024 | 26.85 |
| May 02, 2024 | 24.75 |
| May 01, 2024 | 21.97 |
| April 30, 2024 | 20.95 |
| April 29, 2024 | 20.02 |
| April 26, 2024 | 26.70 |
| April 25, 2024 | 29.60 |
| April 24, 2024 | 29.57 |
| April 23, 2024 | 30.38 |
| April 22, 2024 | 28.72 |
| April 19, 2024 | 28.86 |
| April 18, 2024 | 31.34 |
| April 17, 2024 | 32.44 |
| April 16, 2024 | 29.24 |
| April 15, 2024 | 31.68 |
| April 12, 2024 | 42.91 |
| April 11, 2024 | 46.22 |
| April 10, 2024 | 43.89 |
| April 09, 2024 | 57.10 |
| April 08, 2024 | 59.00 |
| April 05, 2024 | 64.42 |
| April 04, 2024 | 66.31 |
| April 03, 2024 | 69.27 |
| April 02, 2024 | 86.16 |
| Date | Value |
|---|---|
| April 01, 2024 | 88.70 |
| March 28, 2024 | 87.85 |
| March 27, 2024 | 79.40 |
| March 26, 2024 | 78.64 |
| March 25, 2024 | 81.09 |
| March 22, 2024 | 91.23 |
| March 21, 2024 | 94.61 |
| March 20, 2024 | 96.30 |
| March 19, 2024 | 88.27 |
| March 18, 2024 | 87.85 |
| March 15, 2024 | 80.25 |
| March 14, 2024 | 84.02 |
| March 13, 2024 | 81.85 |
| March 12, 2024 | 89.54 |
| March 11, 2024 | 97.99 |
| March 08, 2024 | 105.59 |
| March 07, 2024 | 104.20 |
| March 06, 2024 | 98.95 |
| March 05, 2024 | 101.20 |
| March 04, 2024 | 101.20 |
| March 01, 2024 | 99.70 |
| February 29, 2024 | 101.20 |
| February 28, 2024 | 99.70 |
| February 27, 2024 | 99.70 |
| February 26, 2024 | 96.70 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5263
Minimum
Dec 19 2022
109.44
Maximum
Jan 12 2024
7.520
Average
2.046
Median
Price to Book Value Benchmarks
| Fortress Biotech Inc | 1.510 |
| Avinger Inc | -- |
| AIM ImmunoTech Inc | 2.248 |
| Protalix BioTherapeutics Inc | 2.524 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 0.28 |
| Earnings Yield | -2.14K% |
| Market Cap | 2.909M |